Literature DB >> 22502988

Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.

Alkomiet Hasan1, Thomas Wobrock, Christian Grefkes, Marcin Labusga, Katrin Levold, Thomas Schneider-Axmann, Peter Falkai, Hendrik Müller, Joachim Klosterkötter, Andreas Bechdolf.   

Abstract

BACKGROUND: Impaired cortical inhibition is a well-established finding in schizophrenia patients and has been linked to dysfunctional gamma-aminobutyric acid (GABA)ergic transmission. However, there have been no previous studies investigating cortical excitability with particular regard to intracortical inhibitory networks in antipsychotic-naive subjects at risk of developing first-episode psychosis.
METHODS: A total of 18 subjects at risk, 18 first-episode schizophrenia patients, and 18 healthy control subjects were included in this study. Transcranial magnetic stimulation over the left primary motor cortex was used to determine short-latency intracortical inhibition, intracortical facilitation, and the contralateral silent period (CSP). Short-latency intracortical inhibition can be considered as a parameter of GABA type A (GABA(A))-mediated inhibition and it has been proposed that CSP can test GABA type B (GABA(B))-mediated inhibitory intracortical networks.
RESULTS: Subjects at risk and first-episode patients showed a reduced short-latency intracortical inhibition compared with healthy control subjects, suggesting reduced GABA(A)-mediated inhibition. First-episode patients had a prolonged CSP duration compared with the other two groups, implying a GABA(B) imbalance only in patients with full-blown psychosis. Analyses did not reveal group differences for intracortical facilitation.
CONCLUSIONS: These results indicate specific alterations in inhibitory cortical networks in subjects at risk and in first-episode patients. It appears that there is already a cortical inhibitory deficit in at-risk individuals. These results suggest a possible GABA(A) dysfunction early in the disease course, whereas alterations in GABA(B) functionality seem to occur later in the disease's progression. Future longitudinal studies will be needed to clarify this inhibitory deficit and its relation to the transition to psychosis.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502988     DOI: 10.1016/j.biopsych.2012.03.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  [The German research network for mental disorders].

Authors:  M Bauer; T Banaschewski; A Heinz; I Kamp-Becker; A Meyer-Lindenberg; F Padberg; M A Rapp; R Rupprecht; F Schneider; T G Schulze; H-U Wittchen
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

2.  Lasting modulation effects of rTMS on neural activity and connectivity as revealed by resting-state EEG.

Authors:  Lei Ding; Guofa Shou; Han Yuan; Diamond Urbano; Yoon-Hee Cha
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-25       Impact factor: 4.538

Review 3.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

4.  Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.

Authors:  Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong
Journal:  Biol Psychiatry       Date:  2018-06-21       Impact factor: 13.382

5.  The role of white matter microstructure in inhibitory deficits in patients with schizophrenia.

Authors:  Xiaoming Du; Peter Kochunov; Ann Summerfelt; Joshua Chiappelli; Fow-Sen Choa; L Elliot Hong
Journal:  Brain Stimul       Date:  2016-11-12       Impact factor: 8.955

6.  A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia.

Authors:  Meng di Hou; Viviana Santoro; Andrea Biondi; Sukhi S Shergill; Isabella Premoli
Journal:  J Psychiatry Neurosci       Date:  2021-12-21       Impact factor: 6.186

7.  Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.

Authors:  Xiaoming Du; L Elliot Hong
Journal:  Psychiatry Res       Date:  2018-06-19       Impact factor: 3.222

Review 8.  Modulating neural plasticity with non-invasive brain stimulation in schizophrenia.

Authors:  Alkomiet Hasan; Thomas Wobrock; Tarek Rajji; Berend Malchow; Zafiris J Daskalakis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-24       Impact factor: 5.270

Review 9.  Cortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulation.

Authors:  Nigel C Rogasch; Zafiris J Daskalakis; Paul B Fitzgerald
Journal:  Schizophr Bull       Date:  2013-05-30       Impact factor: 9.306

10.  Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models.

Authors:  Roberto Frau; Valentina Bini; Giuliano Pillolla; Pari Malherbe; Alessandra Pardu; Andrew W Thomas; Paola Devoto; Marco Bortolato
Journal:  CNS Neurosci Ther       Date:  2014-04-07       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.